Performance of an ultrasound diagnostic algorithm for acute dyspneic patients in the emergency department: an EMERALD-US protocol.
Deborah Jaeger, Charlene Duchanois, Kevin Duarte...
https://pubmed.ncbi.nlm.nih.gov/40784781/Actively Recruiting
Led by CHOUIHED Tahar · Updated on 2025-01-16
225
Participants Needed
7
Research Sites
4 weeks
Total Duration
Researchers are evaluating a new ultrasound algorithm called EMERALD-US to improve diagnosis of acute non-traumatic dyspnea in patients aged 50 and older admitted to emergency departments. The study aims to assess how accurately this ultrasound method can identify the three main causes of dyspnea heart failure, pneumonia, and obstructive pulmonary disease exacerbation. This is a prospective multicenter study focusing on the emergency setting where rapid and accurate diagnosis is critical for patient outcomes. The ultrasound exams include lung, cardiac, and vascular scans performed within the first hour after the patients initial medical contact in the emergency department. These exams are done by physicians who are not involved in patient care and are later reviewed blindly by a centralized core laboratory. The study also compares the ultrasound diagnosis with the clinical diagnosis made by emergency physicians. Additional laboratory and radiological tests are collected to assess the algorithms diagnostic accuracy for both common and less frequent causes of dyspnea. Participants will undergo ultrasound examinations lasting up to 30 minutes, alongside routine clinical, laboratory, and imaging assessments. The main outcome measured is the final discharge diagnosis determined by a panel of three senior physicians, based on all clinical data and hospital stay lasting about two weeks. The study also monitors patient management time in the emergency department and 30-day mortality. Researchers will examine the feasibility of using the ultrasound algorithm in emergency settings and its impact on improving diagnostic accuracy and patient survival.
CONDITIONS
Feasibility and Accuracy of an Ultrasound Algorithm for Acute Dyspnea Diagnosis in the Emergency Department
T
Tahar CHOUIHED, MD
N
Nicolas GIRERD, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
CHOUIHED Tahar
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 30 minutes
Participants undergo an ultrasound exam using the EMERALD-US algorithm within the first hour after first medical contact in the emergency department to help diagnose causes of acute dyspnea.
1 visit (in-person)
Duration - Approximately 2 weeks (from admission to discharge)
Participants are monitored during their hospitalization to assess the main discharge diagnosis and patient management time in the emergency department.
Hospital stay with approximately 24 hours in the emergency department
Duration - 30 days
Participants are followed up to assess all-cause mortality at 30 days after admission.
1 follow-up contact
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Deborah Jaeger, Charlene Duchanois, Kevin Duarte...
https://pubmed.ncbi.nlm.nih.gov/40784781/CHOUIHED Tahar
Lead Sponsor